Return On Assets of VYNE Therapeutics Inc. from 30 Sep 2018 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
VYNE Therapeutics Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2018 to 30 Jun 2025.
  • VYNE Therapeutics Inc. Return On Assets for the quarter ending 30 Jun 2025 was -63%, a 64% decline year-over-year.
  • VYNE Therapeutics Inc. annual Return On Assets for 2024 was -50%, a 23% increase from 2023.
  • VYNE Therapeutics Inc. annual Return On Assets for 2023 was -64%, a 43% decline from 2022.
  • VYNE Therapeutics Inc. annual Return On Assets for 2022 was -45%, a 34% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

VYNE Therapeutics Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -63% -25% -64% 01 Apr 2025 30 Jun 2025
Q1 2025 -59% -9% -18% 01 Jan 2025 31 Mar 2025
Q4 2024 -50% +15% +23% 01 Oct 2024 31 Dec 2024
Q3 2024 -39% +69% +64% 01 Jul 2024 30 Sep 2024
Q2 2024 -39% +56% +59% 01 Apr 2024 30 Jun 2024
Q1 2024 -50% +25% +34% 01 Jan 2024 31 Mar 2024
Q4 2023 -64% -19% -43% 01 Oct 2023 31 Dec 2023
Q3 2023 -107% -65% -152% 01 Jul 2023 30 Sep 2023
Q2 2023 -95% -40% -73% 01 Apr 2023 30 Jun 2023
Q1 2023 -75% -20% -36% 01 Jan 2023 31 Mar 2023
Q4 2022 -45% +23% +34% 01 Oct 2022 31 Dec 2022
Q3 2022 -43% +32% +43% 01 Jul 2022 30 Sep 2022
Q2 2022 -55% +18% +25% 01 Apr 2022 30 Jun 2022
Q1 2022 -56% +140% +72% 01 Jan 2022 31 Mar 2022
Q4 2021 -68% +139% +67% 01 Oct 2021 31 Dec 2021
Q3 2021 -74% +137% +65% 01 Jul 2021 30 Sep 2021
Q2 2021 -73% +142% +66% 01 Apr 2021 30 Jun 2021
Q1 2021 -196% -104% -113% 01 Jan 2021 31 Mar 2021
Q4 2020 -207% -132% -175% 01 Oct 2020 31 Dec 2020
Q3 2020 -211% -149% -237% 01 Jul 2020 30 Sep 2020
Q2 2020 -215% -167% -346% 01 Apr 2020 30 Jun 2020
Q1 2020 -92% -55% -150% 01 Jan 2020 31 Mar 2020
Q4 2019 -75% -43% -135% 01 Oct 2019 31 Dec 2019
Q3 2019 -63% -33% -107% 01 Jul 2019 30 Sep 2019
Q2 2019 -48% 01 Apr 2019 30 Jun 2019
Q1 2019 -37% 01 Jan 2019 31 Mar 2019
Q4 2018 -32% 01 Oct 2018 31 Dec 2018
Q3 2018 -30% 01 Jul 2018 30 Sep 2018

VYNE Therapeutics Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -50% +15% +23% 01 Jan 2024 31 Dec 2024
2023 -64% -19% -43% 01 Jan 2023 31 Dec 2023
2022 -45% +23% +34% 01 Jan 2022 31 Dec 2022
2021 -68% +139% +67% 01 Jan 2021 31 Dec 2021
2020 -207% -116% -128% 01 Jan 2020 31 Dec 2020
2019 -91% -45% -97% 01 Jan 2019 31 Dec 2019
2018 -46% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.